Hackensack University Medical Center Cancer Center
Hackensack, New Jersey 07601
0 studies enrolling now · 47 studies all time
What they study most
Brain Tumor, Brain Tumors, Breast Cancer, Cancer, Central Nervous System Tumor, Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Kidney Cancer, Leukemia, Liver Cancer, Long-term Effects Secondary to Cancer Therapy in Children
Studies at this site
- Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes — Running, not enrolling
- High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma — Running, not enrolling
- Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy — Completed
- Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) — Completed
- Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer — Completed
- Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma — Completed
- Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia — Completed
- Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia — Completed
- Pharmacokinetics of Daunorubicin in Young Patients With Cancer — Completed
- High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma — Completed
- Radiation Therapy in Treating Young Patients With Gliomas — Completed
- Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma — Completed
- Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation — Completed
- Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma — Completed
- Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors — Completed
- Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma — Completed
- Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma — Completed
- Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors — Completed
- Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia — Completed
- Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC — Completed
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes — Completed
- Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin — Completed
- Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's Lymphoma — Completed
- Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate — Completed
- Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma — Completed
- hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma — Completed
- Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma — Completed
- Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma — Completed
- Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma — Stopped early
- Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma — Completed
- Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma — Completed
- Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma — Completed
- Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma — Status unconfirmed
- Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia — Completed
- Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes — Completed
- Brain Function in Children Previously Treated on Clinical Trials POG-9605 and POG-9201 — Completed
- Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma — Stopped early
- Fluphenazine in Treating Patients With Refractory Advanced Multiple Myeloma — Completed
- Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma — Completed
- Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors — Completed
- Combination Chemotherapy in Treating Children With Progressive Brain Tumors — Completed
- Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma — Completed
- Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma — Completed
- Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma — Withdrawn before enrolling
- Registration and Informed Consent Study for the Childhood Cancer Research Network — Completed
- Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD) — Stopped early
- Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions — Completed